Literature DB >> 9617305

HIV seroprevalence among male prison inmates in the Wisconsin Correctional System.

N J Hoxie1, M H Chen, A Prieve, B Haase, J Pfister, J M Vergeront.   

Abstract

OBJECTIVE: To estimate HIV seroprevalence and the acceptance of voluntary HIV testing among male inmates entering the Wisconsin Correctional System during July 1, 1994-June 30, 1995, and compare these estimates with similar data obtained in 1987-1988.
METHODS: A blinded HIV seroprevalence survey concurrent with a review of voluntary HIV antibody testing records.
RESULTS: HIV test results were obtained for 3,681 (89%) male prison entrants during the study period; 26 (0.7%) were HIV-1 seropositive. Based on this estimate and the total number of male prison entrants (4,134), an estimated 29 HIV-1 seropositive male inmates entered the Wisconsin Correctional System during the study period. Eighty-four percent of all inmates were tested voluntarily. Among inmates testing HIV-1 seropositive, 69% were tested voluntarily.
CONCLUSIONS: These data suggest that HIV-1 seroprevalence among male prison inmates in Wisconsin is low, and is unchanged from the late 1980s; however, a large increase in the prison population has resulted in a substantial increase in the absolute number of HIV-1 seropositive inmates entering the correctional system. Although overall acceptance of voluntary HIV testing is high, nearly one third of HIV-1 seropositive inmates declined voluntary HIV testing.

Entities:  

Mesh:

Year:  1998        PMID: 9617305

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  12 in total

1.  HIV and AIDS risk behaviors in juvenile detainees: implications for public health policy.

Authors:  Linda A Teplin; Amy A Mericle; Gary M McClelland; Karen M Abram
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

2.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

Review 3.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

4.  Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.

Authors:  Amir Houshang Mohammad Alizadeh; Seyed Moayed Alavian; Khalil Jafari; Nastaran Yazdi
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

5.  HIV coping self-efficacy: a key to understanding stigma and HIV test acceptance among incarcerated men in Jamaica.

Authors:  Katherine Andrinopoulos; Deanna Kerrigan; J Peter Figueroa; Richard Reese; Jonathan M Ellen
Journal:  AIDS Care       Date:  2010-03

6.  Establishment of an HIV/sexually transmitted disease programme and prevalence of infection among incarcerated men in Jamaica.

Authors:  K Andrinopoulos; D Kerrigan; J P Figueroa; R Reese; C A Gaydos; L Bennett; B Bloomfield; L Plunkett; C Maru; J M Ellen
Journal:  Int J STD AIDS       Date:  2010-02       Impact factor: 1.359

7.  The association of neoplasms and HIV infection in the correctional setting.

Authors:  Jacques Baillargeon; Brad H Pollock; Charles T Leach; Shou-Jiang Gao
Journal:  Int J STD AIDS       Date:  2004-05       Impact factor: 1.359

8.  Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system.

Authors:  David L Rosen; Victor J Schoenbach; David A Wohl; Becky L White; Paul W Stewart; Carol E Golin
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

9.  Using arrest charge to screen for undiagnosed HIV infection among new arrestees: a study in Los Angeles County.

Authors:  Nina T Harawa; Trista A Bingham; Qiana R Butler; Karen S Dalton; William E Cunningham; Stephanie Behel; Duncan A MacKellar
Journal:  J Correct Health Care       Date:  2009-04

10.  An evaluation of HIV testing among inmates in the North Carolina prison system.

Authors:  David L Rosen; Victor J Schoenbach; David A Wohl; Becky L White; Paul W Stewart; Carol E Golin
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.